Drugs / CD25/71 allodepleted donor T-cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01827579 | Jul 2014 → Jan 2020 | hematopoietic and lymphoid cell neoplasm | University College, London | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD25/71 allodepleted donor T-cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01827579 ↗ |
| Modality | Cell therapy | “Biological: CD25/71 allodepleted donor T-cells” NCT01827579 ↗ |